A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Sonolisib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 27 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.